TOLREMO THERAPEUTICS

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.The company's molecules specifically eradicate those cancer cells that cause drug resistance, enabling physicians to get personalized anti-drug resistance therapies to meaningfully prolong the lives of cancer patients.

#SimilarOrganizations #People #Financial #Event #Website #More

TOLREMO THERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology Pharmaceutical

Founded:

2017-01-01

Address:

Zürich, Zurich, Switzerland

Country:

Switzerland

Website Url:

http://www.tolremo.com

Total Employee:

1+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

16.1 M CHF

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics

Similar Organizations

carrick-therapeutics-logo

Carrick Therapeutics

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

cullgen-logo

Cullgen

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

jounce-therapeutics-logo

Jounce Therapeutics

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

navitor-pharmaceuticals-logo

Navitor Pharmaceuticals

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

obsidian-therapeutics-logo

Obsidian Therapeutics

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

Current Advisors List

michael-sidler_image

Michael Sidler Board Observer @ TOLREMO therapeutics
Board_observer
2018-10-01

stefanie-flückiger-mangual_image

Stefanie Flückiger-Mangual Board of Directors @ TOLREMO therapeutics
Board_member

reinhard-ambros_image

Reinhard Ambros Chairman Of The Board @ TOLREMO therapeutics
Board_member
2019-01-01

emmanuel-savioz_image

Emmanuel Savioz Board of Directors @ TOLREMO therapeutics
Board_member

mark-sumeray_image

Mark Sumeray Board Member @ TOLREMO therapeutics
Board_member
2022-03-01

Current Employees Featured

stefanie-flückiger-mangual_image

Stefanie Flückiger-Mangual
Stefanie Flückiger-Mangual CEO & Co-Founder @ TOLREMO therapeutics
CEO & Co-Founder
2017-01-01

emmanuel-savioz_image

Emmanuel Savioz
Emmanuel Savioz Co-Founder @ TOLREMO therapeutics
Co-Founder

Founder

emmanuel-savioz_image

Emmanuel Savioz

isaac-kobrin_image

Isaac Kobrin

not_available_image

Karl-Heinz Altmann

stefanie-flückiger-mangual_image

Stefanie Flückiger-Mangual

wilhelm-krek_image

Wilhelm Krek

Investors List

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - TOLREMO therapeutics

altos-ventures_image

Altos Ventures

Altos Ventures investment in Series A - TOLREMO therapeutics

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - TOLREMO therapeutics

zürcher-kantonalbank_image

Zürcher Kantonal Bank

Zürcher Kantonal Bank investment in Series A - TOLREMO therapeutics

redalpine-venture-partners_image

Redalpine

Redalpine investment in Series A - TOLREMO therapeutics

Newest Events participated

Participated in Pitch Night 2019: The Future of HealthTech on 2019-06-12 as exhibitor

Official Site Inspections

http://www.tolremo.com

Host Informations
Whois Informations

Loading ...

More informations about "TOLREMO therapeutics" on Search Engine